[ Price : $8.95]
FDA issues a final rule that bans 19 active ingredients including most commonly triclosan and triclocarban from use in over-the-...[ Price : $8.95]
FDA grants Biogen fast track status for aducanumab, an investigational treatment for early Alzheimers disease.[ Price : $8.95]
Ariad Pharmaceuticals completes a rolling NDA submission for its investigational anaplastic lymphoma kinase (ALK) inhibitor, briga...[ Price : $8.95]
Stakeholders praise an agreement with FDA to extend the Generic Drug User Fee Act program for another five years.[ Price : $8.95]
FDA grants Cynapsus Therapeutics a fast track designation for APL-130277, a product candidate for treating off episodes in patient...[ Price : $8.95]
Researchers list in the New England Journal of Medicine steps researchers can take to try to reduce having a clinical trial primar...[ Price : $8.95]
FDA warns healthcare providers about risks associated with using the Baxter Vascu-Guard patch in carotid endarterectomy procedures...[ Price : $8.95]
Thirteen patient and consumer health advocacy organizations question the wisdom of allowing companies to market regulated products...